ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Impact of STEEN vs Gelofusine as Perfusate During Normothermic Ex Vivo liver Perfusion on Outcome of Pig Liver Transplantation.

I. Linares, D. Kollmann, J. Echeverri, M. Kaths, R. Rosales, C. Bruguera, M. Hamar, P. Urbanellis, S. Ganesh, N. Selzner, M. Selzner.

Multiorgan Transplant Program, Toronto General Hospital, Toronto, ON, Canada

Meeting: 2017 American Transplant Congress

Abstract number: B116

Keywords: Graft function, Hepatocytes, Ischemia, Machine preservation

Session Information

Session Name: Poster Session B: Ischemic Injury and Organ Preservation Session II

Session Type: Poster Session

Date: Sunday, April 30, 2017

Session Time: 6:00pm-7:00pm

 Presentation Time: 6:00pm-7:00pm

Location: Hall D1

European and North American clinical trials have used two different perfusate solutions for normothermic ex vivo liver perfusion (NEVLP): Gelofusine (bovine derived gelatin-based solution) and STEEN (Human albumin-based solution). We aimed to determine the effects of the perfusate solution during NEVLP on outcome of pig liver transplantation.

Material and Methods:

Porcine livers were retrieved 30 minutes after circulatory death. Grafts were perfused for 5 hours and transplanted into recipient pigs. Two groups were compared based on the perfusate solution (Gelofusine vs STEEN, n=6, respectively). Hemodynamic variables, liver injury and function were evaluated. AST, alkaline phosphatase, total bilirubin and INR were measured until third postoperative day.

Results:

Hepatic artery flow during perfusion was higher in the STEEN vs Gelofusine group and within physiologic range since the beginning of perfusion (238±90 vs 97±33, p=0.015). Electrolytes and pH from the STEEN but not the Gelofusine group were within normal limits from the time when the perfusion started. Both perfusate groups achieved lactate clearance reaching normal levels by the end of perfusion (Gelofusine: 0.78±0.30 vs STEEN: 0.68±0.60, p=0.80). AST (Gelofusine: 1495±612 vs STEEN: 1160±564), alkaline phosphatase (Gelofusine: 177±128 vs STEEN: 145±47) and total bilirubin levels (Gelofusine: 11±4 vs STEEN: 5±1) were lower in the STEEN group since 1 day after transplantation. Liver function recovery was significantly improved in the STEEN vs Gelofusine perfused livers after transplantation All animals in the STEEN group survived while one pig from the Gelofusine group died on the first postoperative day due to primary non-function.

Conclusion

The characteristics from the STEEN based perfusate resembled more closely the physiologic conditions compared to gelatin-based perfusate. The use of STEEN based perfusate decreases hepatic injury and improves liver function recovery in pig livers retrieved after circulatory death.

CITATION INFORMATION: Linares I, Kollmann D, Echeverri J, Kaths M, Rosales R, Bruguera C, Hamar M, Urbanellis P, Ganesh S, Selzner N, Selzner M. Impact of STEEN vs Gelofusine as Perfusate During Normothermic Ex Vivo liver Perfusion on Outcome of Pig Liver Transplantation. Am J Transplant. 2017;17 (suppl 3).

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

To cite this abstract in AMA style:

Linares I, Kollmann D, Echeverri J, Kaths M, Rosales R, Bruguera C, Hamar M, Urbanellis P, Ganesh S, Selzner N, Selzner M. Impact of STEEN vs Gelofusine as Perfusate During Normothermic Ex Vivo liver Perfusion on Outcome of Pig Liver Transplantation. [abstract]. Am J Transplant. 2017; 17 (suppl 3). https://atcmeetingabstracts.com/abstract/impact-of-steen-vs-gelofusine-as-perfusate-during-normothermic-ex-vivo-liver-perfusion-on-outcome-of-pig-liver-transplantation/. Accessed May 19, 2025.

« Back to 2017 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences